Nad(p)h oxidase and MRP genetic polymorphisms associate with doxorubicin-induced cardiotoxicity

3021 Background: Anthracyclines are widely used in the treatment of many malignancies. Up to 5% patients develop chronic anthracyclin-induced cardiotoxicity (ACT) mostly presenting as arrhythmias o...